Health
Scientists identify key molecules that mediate radioresistance in aggressive brain cancer – News-Medical.Net
Scientists have identified key molecules that mediate radioresistance in glioblastoma multiforme; these molecules are a potential target for the treatment of th…
Reviewed by Emily Henderson, B.Sc.Sep 30 2020
Scientists have identified key molecules that mediate radioresistance in glioblastoma multiforme; these molecules are a potential target for the treatment of this brain cancer.
Glioblastoma multiforme (GBM), is the most aggressive type of brain cancer. It is treated by radiation therapy combined with chemotherapy. However, even with treatment, the five-year survival rate for GBM is less than 7%. One of the major causes for this is that GBM rapidly …
-
General17 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News16 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years
-
General19 hours agoBack-to-back rate cuts tipped when Reserve Bank meets
-
Noosa News19 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland